Price Alert

Ocuphire Pharma Inc. (OCUP)

NASDAQ: OCUP · Real-Time Price · USD

1.17

-0.16 (-12.03%)

At close: Oct 23, 2024, 10:00 PM

Ocuphire Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	32.43M	41.79M	30.32M	36.63M	41.41M	47.16M	50.5M	42.35M	39.98M	38.99M	42.63M	13.86M	17.02M	19.25M	24.53M	22.25M	24.23M	10.6M
Short-Term Investments	n/a	1K	2K	3K	5K	5K	15K	11K	22K	22K	49K	101K	126K	135K	219K	383K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4K	-5K	-6K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	4.58M	4.75M	5.77M	3.33M	2.31M	3.12M	2.33M	11.34M	2.73M	5.3M	4.85M	n/a	n/a	n/a	n/a	n/a	50K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	433K	687K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	883K	n/a
Other Current Assets	1.43M	1.38M	515K	86K	87K	89K	102K	51K	45K	78K	80K	61K	31K	33K	71K	46K	73K	114K
Total Current Assets	38.44M	47.93M	36.61M	40.39M	44.83M	51.84M	53.95M	54.19M	43.46M	45.4M	48.99M	14.56M	17.89M	20.48M	26.07M	23.19M	25.24M	12.11M
Property-Plant & Equipment	226K	239K	252K	n/a	n/a	n/a	n/a	3K	4K	5K	6K	7K	8K	9K	10K	11K	12K	13K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	226K	239K	252K	n/a	n/a	n/a	n/a	3K	4K	5K	6K	7K	8K	9K	10K	11K	12K	13K
Total Assets	38.66M	48.17M	36.86M	40.39M	44.83M	51.84M	53.95M	54.19M	43.47M	45.4M	48.99M	14.57M	17.9M	20.48M	26.08M	23.2M	25.25M	12.13M
Account Payables	1.47M	2.43M	3.15M	844K	634K	2.06M	2.15M	1.89M	2.32M	2.22M	1.07M	1.47M	1.89M	1.58M	1.58M	1.43M	1.5M	1.42M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	215K	538K	n/a	n/a	n/a
Other Current Liabilities	20.19M	24.25M	11.29M	74K	3.14M	3.3M	1.14M	1.55M	3.14M	1.39M	902K	843K	1.09M	1.23M	1.25M	810K	n/a	749K
Total Current Liabilities	20.19M	24.25M	11.29M	6.09M	4.2M	5.79M	4.04M	3.91M	5.76M	4.15M	2.75M	2.69M	3.3M	3.21M	3.85M	2.64M	2.7M	2.31M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.22M	1.07M	n/a	n/a	1.79M	2.12M	n/a	n/a	n/a
Total Liabilities	21.19M	24.25M	11.29M	6.09M	4.2M	5.79M	4.04M	3.91M	5.76M	4.15M	2.75M	2.69M	3.3M	3.21M	3.85M	2.64M	2.7M	2.31M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	215K	538K	n/a	n/a	n/a
Common Stock	6K	5K	3K	3K	3K	3K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	1K
Retained Earnings	-154.61M	-147.19M	-139M	-103.86M	-96.34M	-88.57M	-81.47M	-76.67M	-82.23M	-77.27M	-71.48M	-105.42M	-100.89M	-95.96M	-89.37M	-83.06M	-78.83M	-71.69M
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	n/a	-0.00	0.00	n/a	-0.00	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	-0.00
Shareholders Equity	17.47M	5.07M	6.72M	34.3M	40.64M	46.06M	49.91M	50.28M	37.7M	41.25M	46.24M	11.88M	14.6M	17.27M	22.22M	20.57M	22.55M	9.82M
Total Investments	n/a	n/a	n/a	3K	5K	5K	15K	11K	22K	22K	49K	101K	126K	135K	219K	383K	n/a	n/a